Candriam Equities L Oncology Impact Class BF Fonds
2.827,52
EUR
+1,73
EUR
+0,06
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| AstraZeneca PLC | GB0009895292 | 5,98% |
| Eli Lilly and Co | US5324571083 | 5,73% |
| Merck & Co Inc | US58933Y1055 | 5,56% |
| Roche Holding AG | CH0012032048 | 5,02% |
| Siemens Healthineers AG Registered Shares | DE000SHL1006 | 4,72% |
| Novo Nordisk AS Class B | DK0062498333 | 4,21% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,18% |
| Novartis AG Registered Shares | CH0012005267 | 4,06% |
| Amgen Inc | US0311621009 | 3,97% |
| Hologic Inc | US4364401012 | 3,58% |
| Sonstige | 53,00% |